Free Trial

Cidara Therapeutics (CDTX) News Today

Cidara Therapeutics logo
$65.62 +0.75 (+1.16%)
Closing price 04:00 PM Eastern
Extended Trading
$65.63 +0.01 (+0.02%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CDTX Latest News

Cidara Therapeutics (CDTX) Receives a Buy from Needham
Cidara (CDTX) Q2 Cash Surges 163%
Image of dna strand and data processing over world map on black background. Global technology, computing and digital interface concept digitally generated image. — Photo
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains (CDTX)
With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?
Get Cidara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDTX Media Mentions By Week

CDTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDTX
News Sentiment

1.44

0.93

Average
Medical
News Sentiment

CDTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDTX Articles
This Week

7

4

CDTX Articles
Average Week

Get the Latest News and Ratings for CDTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:CDTX) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners